Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with Antiphospholipid syndrome - A review

被引:9
作者
De Carolis, Sara [1 ]
Botta, Angela [1 ]
Garofalo, Serafina [1 ]
Ferrazzani, Sergio [1 ]
Martino, Carmelinda [1 ]
Fatigante, Gabriella [1 ]
Caforio, Leonardo [1 ]
Caruso, Alessandro [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy
来源
AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS | 2007年 / 1108卷
关键词
antiphospholipid syndrome; pregnancy outcome; uterine artery Doppler velocimetry;
D O I
10.1196/annals.1422.056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In pregnant women, antiphospholipid syndrome (APS) is associated with an increased risk for preeclampsia, fetal intrauterine growth restriction, and other complications related to uteroplacental insufficiency. In normal pregnancy, impedance to flow in the uterine arteries decreases with gestation, as the likely consequence of the physiologic change of spiral arteries into low-resistance vessels. The presence of antiphospholipid antibodies can impair this vascular adaptation, resulting in a reduced placental perfusion. Doppler investigation provides a noninvasive method for the study of uteroplacental blood flow. Several studies were performed to detect the predictive role of uterine artery Doppler velocimetry in relation to pregnancy outcome in APS patients. In some studies, a high resistance index in the uterine arteries strongly predicted the subsequent development of obstetric complications. In other studies, persistent bilateral uterine artery notches identified the risk of preeclampsia and fetal intrauterine growth restriction. To date, the uterine artery Doppler velocimetry resulted to be a useful tool for identifying APS pregnancies at risk for adverse pregnancy outcome. These findings might have important implications for the management of these patients.
引用
收藏
页码:530 / 539
页数:10
相关论文
共 24 条
[1]   Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin [J].
Backos, M ;
Rai, R ;
Baxter, N ;
Chilcott, IT ;
Cohen, H ;
Regan, L .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (02) :102-107
[2]   Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications [J].
Bar, J ;
Mashiah, R ;
Cohen-Sacher, B ;
Hod, M ;
Orvieto, R ;
Ben-Rafael, Z ;
Lahav, J .
THROMBOSIS RESEARCH, 2001, 101 (04) :235-241
[3]   Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy [J].
Bats, AS ;
Lejeune, V ;
Cynober, E ;
Safar, E ;
Gonzales, M ;
Milliez, J ;
Carbonne, B .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 114 (02) :125-129
[4]   PREDICTIVE VALUE OF UTERINE ARTERY VELOCITY WAVE-FORMS IN PREGNANCIES COMPLICATED BY SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME [J].
BENIFLA, JL ;
TCHOBROUTSKY, C ;
UZAN, M ;
SULTAN, Y ;
WEILL, BJ ;
LAUMONDBARNY, S .
FETAL DIAGNOSIS AND THERAPY, 1992, 7 (3-4) :195-202
[5]  
BLUMENFELD Z, 1991, OBSTET GYNECOL, V78, P584
[6]  
Branch DW, 2004, THROMB RES, V114, P415, DOI 10.1016/j.thromres.2004.08.005
[7]   Pregnancy, vascular tone, and maternal hemodynamics: A crucial adaptation [J].
Carbillon, L ;
Uzan, M ;
Uzan, S .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2000, 55 (09) :574-581
[8]   Uteroplacental circulation development: Doppler assessment and clinical importance [J].
Carbillon, L ;
Challier, JC ;
Alouini, S ;
Uzan, M ;
Uzan, S .
PLACENTA, 2001, 22 (10) :795-799
[9]  
CARUSO A, 1993, OBSTET GYNECOL, V82, P970
[10]   Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death [J].
Chamley, LW ;
Duncalf, AM ;
Mitchell, MD ;
Johnson, PM .
LANCET, 1998, 352 (9133) :1037-1038